Holding(s) in Company
June 25 2008 - 6:43AM
UK Regulatory
RNS Number : 4787X
Hikma Pharmaceuticals Plc
25 June 2008
Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
Hikma Pharmaceuticals PLC
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights Yes
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are
attached
An event changing the breakdown of voting rights
Other (please specify):______________
Genesis Asset Managers LLP
3. Full name of person(s)
subject to notification
obligation:
4. Full name of shareholder(s)
(if different from 3):
12 June 2008
5. Date of transaction (and
date on which the threshold is
crossed or reached if
different):
23 June 2008
6. Date on which issuer
notified:
3%
7. Threshold(s) that is/are
crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of shares Situation previous to the triggering Resulting situation after the triggering transaction
If possible use ISIN transaction
code
GB00B0LCW083
Number of shares Number of voting Number of shares Number of voting Percentage of voting
rights rights rights
5,560,993
5,560,993 5,647,800
Direct Indirect Direct Indirect
5,647, N/A 3 N/A
800
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion No. of voting rights Percentage of voting
period/date that may be acquired rights
(if the instrument
exercised/converted)
N/A
Total (A+B)
Number of voting rights Percentage of voting rights
5,647,800 3%
9. Chain of controlled undertakings through which the voting rights and /or
the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information:
14 Contact name: Henry Knowles
15. Contact telephone name: 0207 399 2799
For notes on how to complete form TR-1 please see the FSA website.
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in shares
A: Identity of the persons or legal entity subject to the notification obligation
Full name
(including legal form of legal entities)
Contact address
(registered office for legal entities)
Phone number & email
Other useful information
(at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information
(e.g. functional relationship with the person or legal entity subject to the
notification obligation)
C: Additional information
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVSWRWARNURR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
